OBESITY, DEFINED AS 20% OR more than the ideal weight or body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters) of 30 or more, has reached epidemic levels in the United States, affecting more than 30% of adults. Annual direct costs for treating obesityrelated medical illnesses have been estimated at nearly $51.6 billion; the annual US expenditure on weight reduction exceeds $30 billion. It was recently estimated that the prevalence of obesity in US adults increased by 8% during the past decade. In the 21st century, obesity may be the number 1 US public health problem (http://www .surgeongeneral.gov/topics/obesity/). Morbid or severe obesity was traditionally defined as a weight of 45 kg or more or 100% over ideal body weight defined by standard life insurance tables. More recent classification systems define morbid obesity as a BMI of 40 or more or a BMI of 35 or more in the presence of comorbidities. The prevalence of severe obesity based on US 19992000 population data was estimated to be 3.1% in men and 6.7% in women. Inapublishedreportofmortalityrates in patients who were morbidly obese, mortality was 12 times higher in men aged 25 to 34 years and 6 times higher in men aged 35 to 44 years vs men with healthy weight of the same age. Because even modest weight loss (10%-15% of initialweight)usuallyresults inimprovement or resolution of multiple medical comorbidities, surgical treatment of severe obesity appears to be cost-effective by eliminating use of medications and absenteeism from work in patients who were previously morbidly obese. Gastric Restrictive Operations There are 3 types of gastric restrictive operations: stapled gastroplasty, gastric banding, and conventional Rouxen-Y gastric bypass. In stapled gastroplasty, the stomach is partitioned close to the gastroesophageal junction creating a small-capacity upper gastric pouch with a small calibrated outlet leading from the upper pouch to the remainder of the digestive tract (FIGURE, A). Early weight loss results after banded gastroplasty have been acceptable with a mean excess weight (difference between preoperative and ideal weight) loss reported in the range of 60% (or approximately 30% of initial preoperative weight lost). The early morbidity rate (within the first 30 days) for banded gastroplasty is less than 10% and the perioperative mortality rate is less than 1.0%. However, many patients regain a substantial portion of their lost weight between 3 and 5 years, postoperatively. Vertical-banded gastroplasty has been shown to adversely alter postoperative eating behavior toward sweets and ice cream, which, in part, explain inferior weight loss results in comparison with Roux-en-Y gastric bypass; a nearly 80% failure rate has been reported 10 years following vertical-banded gastroplasty. Gastroplasty has recently fallen into disfavor due to poor weight loss maintenance and a 15% to 20% rate of reoperation for either stomal outlet stenosis or severe gastroesophageal reflux. Gastric banding uses a premeasured prosthetic device to restrict oral intake (Figure, B). The circumference of the band is generally in the range of 5.0 cm, similar to the measurement used for gastroplasty. Kuzmak introduced an inflatable band in which the diameter of the band can be adjusted by infusion of saline through a subcutaneous reservoir. Complication rates with the early techniques of gastric banding were relatively high due to stenosis, erosion, or both of the band, frequently requiring reoperation. Weight loss results and complication rates with the inflatable bands are better than those observed after the earlier banding techniques. Although erosion of the inflatable bands is relatively uncommon, usability of the subcutaneous reservoir deteriorates over time. Weight loss with gastric banding has been less consistent than weight loss reported after banded gastroplasty and gastric bypass. Gastric bypass combines gastric restriction with a small amount of subclinical malabsorption. Although absorption of iron and vitamin B12 is decreased after gastric bypass, malabsorption of protein, carbohydrate, and fat has not been reported after gastric bypass performed with short Roux limb lengths. In gastric bypass, the upper stomach is completely closed off, thereby excluding more than 95% of the stomach, all of the duodenum, and 15 to 20 cm of proximal jejunum from digestive continuity. The Roux-en-Y technique (Figure, C) is currently the preferred method of gastric bypass. Weight loss results with the Rouxen-Y technique have been superior to thoseobservedafterothergastric restrictive operations in multiple clinical comparisons. Mean excess weight loss in gastric bypass patients typically ranges from 65% to 75%, which corresponds to loss of approximately 35% of initial weight. However, there is some degree of recidivism between 3 and 5
[1]
K. Flegal,et al.
Prevalence and trends in obesity among US adults, 1999-2000.
,
2002,
JAMA.
[2]
M. Deitel.
How Much Weight Loss is Sufficient to Overcome Major Co-Morbidities?
,
2001,
Obesity surgery.
[3]
C. J. Rosenquist,et al.
Laparoscopic Versus Open Gastric Bypass: A Randomized Study of Outcomes, Quality of Life, and Costs
,
2001,
Annals of surgery.
[4]
H. Sugerman,et al.
High Failure Rate After Laparoscopic Adjustable Silicone Gastric Banding for Treatment of Morbid Obesity
,
2001,
Annals of surgery.
[5]
L. Sjöström,et al.
The Swedish Obese Subjects (SOS) study—rationale and results
,
2001,
International Journal of Obesity.
[6]
K. Kelly,et al.
Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity
,
2000,
Journal of Gastrointestinal Surgery.
[7]
Alan C. Wilson,et al.
Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity
,
2000,
Journal of Gastrointestinal Surgery.
[8]
D. W. Hess,et al.
Biliopancreatic Diversion with a Duodenal Switch
,
1998,
Obesity surgery.
[9]
G. Dohm,et al.
A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?
,
1998,
Annals of surgery.
[10]
G A Colditz,et al.
Current estimates of the economic cost of obesity in the United States.
,
1998,
Obesity research.
[11]
N. Scopinaro,et al.
Biliopancreatic diversion for obesity at eighteen years.
,
1996,
Surgery.
[12]
S. Biron,et al.
Biliopancreatic Diversion with a New Type of Gastrectomy: Some Previous Conclusions Revisited
,
1995,
Obesity surgery.
[13]
E. Bixler,et al.
Comparison of the costs associated with medical and surgical treatment of obesity.
,
1995,
Surgery.
[14]
R. Cody,et al.
Weight Loss and Dietary Intake After Vertical Banded Gastroplasty and Roux‐en‐Y Gastric Bypass
,
1994,
Annals of surgery.
[15]
J. Carson,et al.
The effect of gastric bypass surgery on hypertension in morbidly obese patients.
,
1994,
Archives of internal medicine.
[16]
D. McClish,et al.
Obesity and lower urinary tract function in women: effect of surgically induced weight loss.
,
1992,
American journal of obstetrics and gynecology.
[17]
J. Gorman,et al.
Long-limb gastric bypass in the superobese. A prospective randomized study.
,
1992,
Annals of surgery.
[18]
G. Blackburn,et al.
Impact of gastric restrictive surgery on hypertension in the morbidly obese.
,
1992,
American journal of surgery.
[19]
H. Sugerman,et al.
Gastric bypass for treating severe obesity.
,
1992,
The American journal of clinical nutrition.
[20]
G A Colditz,et al.
Economic costs of obesity.
,
1992,
The American journal of clinical nutrition.
[21]
Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.
,
1992,
The American journal of clinical nutrition.
[22]
J. Barboriak,et al.
Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity.
,
1990,
The American journal of clinical nutrition.
[23]
R. A. Forse,et al.
Late results of vertical banded gastroplasty for morbid and super obesity.
,
1990,
Surgery.
[24]
R. Gorman,et al.
The dilemma of outcome assessment after operations for morbid obesity.
,
1989,
Surgery.
[25]
P. Mortensen,et al.
[Gastric banding].
,
1989,
Ugeskrift for laeger.
[26]
G. Vetrovec,et al.
Hemodynamic Dysfunction in Obesity Hypoventilation Syndrome and the Effects of Treatment with Surgically Induced Weight Loss
,
1988,
Annals of surgery.
[27]
M. Deitel,et al.
Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery.
,
1988,
Journal of the American College of Nutrition.
[28]
W. Pories,et al.
The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass.
,
1987,
Annals of surgery.
[29]
P. Lavie,et al.
The effect of surgical weight reduction on sleep quality in obesity-related sleep apnea syndrome.
,
1985,
Surgery.
[30]
M. Alpert,et al.
Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity.
,
1985,
The American journal of cardiology.
[31]
K. Printen,et al.
Pregnancy following gastric bypass for the treatment of morbid obesity.
,
1982,
The American surgeon.
[32]
Halverson Jd,et al.
Gastric bypass: analysis of weight loss and factors determining success.
,
1981
.
[33]
E. Drenick,et al.
Excessive mortality and causes of death in morbidly obese men.
,
1980,
JAMA.